Pulmonary Hypertension on Prognosis of Acute Myocardial Infarction Patients With Reduced Left Ventricular Function
NCT ID: NCT06186713
Last Updated: 2024-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
4784 participants
OBSERVATIONAL
2023-03-30
2023-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study
NCT06753981
Effect of Inhaled Albuterol in Pulmonary Hypertension
NCT03270332
Stress Ventricular Function in Evaluating Patients With Pulmonary Hypertension
NCT02647034
The Effects of Pulmonary Hypertension Web-Based Health Care Program on Symptom Management, Social Support, Activity Tolerance, and Quality of Life in Patients With Pulmonary Hypertension.
NCT05908019
Utility of Exercise-induced N-terminal (NT) Pro-brain Natriuretic Peptide Levels in Predicting Prognosis in Asymptomatic Aortic Stenosis
NCT00567437
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pulmonary hypertension (PH) group
The PH group comprised of patients with systolic pulmonary artery pressure (sPAP) ≥ 35mmHg measured by echocardiology.
This was an observational study, and no Intervention was given to the patients.
This was an observational study, and no Intervention was given to the patients.
Control group
The control group included patients with systolic pulmonary artery pressure (sPAP) \<35mmHg measured by echocardiology.
This was an observational study, and no Intervention was given to the patients.
This was an observational study, and no Intervention was given to the patients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
This was an observational study, and no Intervention was given to the patients.
This was an observational study, and no Intervention was given to the patients.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Significant pre-existing heart failure.
* Other comorbidities such as malignancy that may significantly affect prognosis.
* Incomplete clinical data.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Affiliated Hospital Xi'an Jiaotong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yang Yan
Role: PRINCIPAL_INVESTIGATOR
First Affiliated Hospital Xi'an Jiaotong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
First Affiliated Hospital of Xian Jiaotong University
Xi'an, Shaanxi, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Liu Q, Zhao C, Dang P, Li Y, Yan Y. Prognostic value of pulmonary hypertension with a nomogram in acute myocardial infarction patients with reduced left ventricular function. Front Cardiovasc Med. 2024 Apr 22;11:1368139. doi: 10.3389/fcvm.2024.1368139. eCollection 2024.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XJTU1AF2023LSK-406
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.